chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a registered nurse concerning a patient care assistant who on an unspecified date got some of the ROTATEQ (lot number 668953/1137Z, expiry date 05-AUG-2012) in her eye during administration of vaccine to a patient. She was currently experiencing mild discomfort and burning. The patient care assistant was treated with flushing eye with water. She did not seek medical attention. At the time of report the patient care assistant's status was not recovered. Additional information has been requested. This is one of several reports from the same source.
body ache; rash; UTI; tested positive; Vomiting; Nausea; Fatigue; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of URINARY TRACT INFECTION (UTI), MYALGIA (body ache), COVID-19 (tested positive), RASH (rash) and VOMITING (Vomiting) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Nausea, COVID-19 on 22-Jan-2021 and COPD. Concomitant products included ELECTROLYTES NOS, GLUCOSE (PEDIALYTE [ELECTROLYTES NOS;GLUCOSE]) for Dehydration, ONDANSETRON (ZOFRAN [ONDANSETRON]) for Nausea, PREDNISOLONE for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced COVID-19 (tested positive), VOMITING (Vomiting), NAUSEA (Nausea) and FATIGUE (Fatigue). On 25-Jan-2021, the patient experienced URINARY TRACT INFECTION (UTI). On 26-Jan-2021, the patient experienced RASH (rash). On an unknown date, the patient experienced MYALGIA (body ache). On 25-Jan-2021, VOMITING (Vomiting) outcome was unknown. On 29-Jan-2021, FATIGUE (Fatigue) outcome was unknown. On 31-Jan-2021, URINARY TRACT INFECTION (UTI) and RASH (rash) outcome was unknown. At the time of the report, MYALGIA (body ache), COVID-19 (tested positive) and NAUSEA (Nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Chest X-ray: no signs of pneumonia/infection. On 22-Jan-2021, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient  lived on Pedialyte for 2 weeks. He had no appetite, but this helped him from getting dangerously dehydrated   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: addition of lab data and medical history
very tired; hands are shaking; A spontaneous report was received from a consumer concerning a 68-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fatigue (very tired) and tremor (hands are shaking).  The patient's medical history includes Parkinson's disease. No relevant concomitant medications was provided by the reporter.  On 24 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: Unknown) through unknown route in the right arm for prophylaxis of COVID-19 infection.  On 25 Feb 2021, the patient stated he was feeling very tired and his hands were shaking.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events was unknown.
localized allergic reaction of right upper arm at injection site that presented on day 10 following vaccination
Information has been received from a physician concerning an approximately 30 months old female who received 3 doses of PEDVAXHIB (lot# not reported). In May 2008, the patient experienced "H Flu Type B epiglottitis" which was infection of epiglottis and was hospitalized (unspecified number of days in the hospital). Subsequently, the patient recovered from H Flu Type B epiglottitis. The reporter considered H Flu Type B epiglottitis to be immediately life-threatening. Additional information has been requested.
24hr p/vax pt woke up w/hives & ended up @ ER;hives covered body;DPH q 4hr x 24hr given;
Severe aching of joints, extreme gastrointestinal sounds, frequent green bowel movements with some occuring as loose stools. This persisted 2 1/2 days with no other obvious signs of illness and no fever. 25 years ago I had such severe aching and pain after the injections I omitted the 3rd dose in the series even though I was told this was unrelated to the vaccine. 25 years ago I do not recall having green bowel movements however (no I have not eaten any thing that would generate a green color to bowel movements).
Caller stated that he had never had anxiety before in his life until all of this covid stuff.; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (COMIRNATY), administration date Feb2021 (Batch/Lot number: unknown) as dose 1, single and administration date Feb2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ANXIETY (non-serious) with onset 2021, outcome "unknown", described as "Caller stated that he had never had anxiety before in his life until all of this covid stuff.". Additional information: Caller stated that he was fully vaccinated with the Pfizer Biontech covid 19 vaccine series back in February. Caller reported he was now 8 months plus 5 days out and was seeking information regarding the booster shot and its efficacy since the recommendation was to get the booster dose 6 months later. Caller stated that he had never had anxiety before in his life until all of this covid stuff. Caller was fully vaccinated with both doses in Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient contracted COVID-19 with symptoms of body aches, fever, cough, loss of taste and smell, diarrhea, stomach upset, chest pain/tightness, shortness of breathe, fatigue, and was ill for 7 days. His loss of taste and smell has not fully returned, he can taste some items but has not fully recovered those senses.
Mom appeared @ 1020AM states child had fever & convuls since last night; Temp @ 0125AM 105; rescue squad called & came @ 1030AM; Took child to ER
had the vax still got it/suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: had the vax still got it/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 09-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he/she received Shingles vaccine and still experienced shingles. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Approximately 8 hours following the injection I began experiencing body aches and a headache. Then during the night I developed a fever along with chills and shivering. TYLENOL 500mg was taken. By 9am the fever was gone. Fatigue, headache and body aches continued.
Fever.  Within 24 hours post vax, child developed a beet red face, fever up to 102, vomiting and a pimply rash extending down the trunk of his body. The pt recently recovered from an ear infection and had been treated with Amoxil. The pt was hospitalized. A rotavirus test performed was positive. He was discharged with 24 hours. A copy of this report was forwarded to PMC, manufacturer of IPV. 60 Day follow-up received, no additional data. Follow up information received 06/04/2001 reported that the patient recovered. This case is closed.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a adult patient who received SHINGRIX. On an unknown date, the patient received SHINGIRX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was recovered/resolved. The reporter considered the injection site pain to be related to SHINGRIX. Additional information was reported as follows: The age at vaccination was not reported. The pharmacist reported that the patient experienced severe pain for a couple of days at the injection site after receiving SHINGRIX vaccine.
not able to walk at all; cannot stand up easily; lightheaded; injection site was hard and swollen; injection site was hard and swollen; This spontaneous case was reported by a consumer and describes the occurrence of GAIT INABILITY (not able to walk at all), DYSSTASIA (cannot stand up easily), DIZZINESS (lightheaded), VACCINATION SITE INDURATION (injection site was hard and swollen) and VACCINATION SITE SWELLING (injection site was hard and swollen) in a 98-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Feb-2021, the patient experienced GAIT INABILITY (not able to walk at all), DYSSTASIA (cannot stand up easily), DIZZINESS (lightheaded), VACCINATION SITE INDURATION (injection site was hard and swollen) and VACCINATION SITE SWELLING (injection site was hard and swollen). At the time of the report, GAIT INABILITY (not able to walk at all), DYSSTASIA (cannot stand up easily), DIZZINESS (lightheaded), VACCINATION SITE INDURATION (injection site was hard and swollen) and VACCINATION SITE SWELLING (injection site was hard and swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
09/16/2005 3:15pm pt received Hep B #1 and Td Booster, no complaints prior to injection. Seen personal MD today this am. DX sinus infection. 09/16/2005 3:30pm walking down hallway pt felt weak, dizzy, seeing black floating dots. Laid down on floor moaning, sweating, complained of left hand numbness. Also cold and clammy feeling skin. Respiratory slow labored. Never lost consciousness. Remain alert and oriented to person, place and time. Vomited a large amount. EMS called and transported to Hospital.
Hives,  swollen eyes and lips. Redness around the vaccine area. Feeling weak
first dose 23-Oct-2019, second dose has not been administered; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 23rd October 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable to this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow up.
Hospitalized 12/26/21-12/31/21 Cough, lightheaded,  dizziness, nausea, weakness, PNA, decreased appetite, sore throat, dyspnea
Kidney stones; extremely sick; pain; This is a spontaneous report from a Pfizer Sponsored Program. A contactable female consumer (patient) of unspecified age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) via an unspecified route of administration on 04Mar2021 as a single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. On 22Mar2021, the patient experienced kidney stones which required hospitalization. The patient reported she was extremely sick right now (Mar2021). She reported she was on 5 different medications (unspecified products), that they haven't done anything yet, she was just diagnosed with kidney stones. She also stated she has an appointment to go and do something about it and that the medications were to keep her from not screaming from pain (Mar2021). The patient is scheduled for the second dose of the COVID-19 vaccine tomorrow (25Mar2021). The clinical outcome of kidney stones, extremely sick, and pain was unknown.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow-up.
'pops just passed away'; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death, medically significant), outcome "fatal", described as "'pops just passed away'". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  Additional information: It was reported the reporter stated that their 'pops just passed away' (not clarified) with.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: 'pops just passed away'
Severe chills / fever / aches / nausea. Onset 6:30/7pm. Pt. took ADVIL. Pt. much better by 12-6-12.
She administered a dose of Proquad in error to a 10 and 1/2 month old baby.; no adverse effect reported; This spontaneous report has been received from a nurse and refers to a 10- and 1/2-month-old patient of unknown gender. The patient's concurrent condition, medical history and concomitant medication were not provided.   On an unknown date, the patient was vaccinated by error with a dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot #, expiration date, dose, route of administration and anatomical location of vaccine were not provided) for prophylaxis. No adverse effects were reported.
No adverse events; During temperature excursion case, customer reported that improperly stored vaccine was administered to 10 separate patients. No additional AE reported, No PQC reported.  Names of vaccines involved (including lot/exp) PEDVAX HIB T042013 exp 07/22/202; This spontaneous report was received from an office manager, and refers to a 3-month-old patient of unspecified gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 24-MAR-2022, the patient was vaccinated with haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, lot #T042013, expiration date: 22-JUL-2023, administered for prophylaxis (strength, and route of administration were not provided).  On an unspecified date, the dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) underwent a temperature excursion of 11.43 Celsius (°C) degrees, for a time frame of 4 hours and 45 minutes. There were no previous temperature excursions.   No adverse events were reported.  This is one of 10 cases received from the same source.; Sender's Comments:  US-009507513-2205USA003131: US-009507513-2205USA002848: US-009507513-2205USA002913: US-009507513-2205USA002951: US-009507513-2205USA002965: US-009507513-2205USA002988: US-009507513-2205USA003118: US-009507513-2205USA003121: US-009507513-2205USA003266:
pt recvd flu vax & the next day devel a sore throat & fever to 102-103 which lasted into the evening; 5 days later devel an all-over body macular, non-pruritic rash;
Patient received GARDASIL vaccine 8/5/09, 12/12/09 and 2/15/10. Pt diagnosed with type 1 diabetes on 3/29/10. Sister also with IDDM (Vaers Filled out) Parents Questioning Role of vaccine.
Moderate to Severe Vomiting after about 3 hours of nausea. Given Zofran after 3rd vomit. Immediately ceased and rest of day was better (ish).  No other family members sick.
fever and chills, headache, nausea muscle aches, fatigue  treated with tylenol   felt fine after 24 hours
Headache - Nausea - Tiredness (acute) - Body Aches - Diarrhea. Lasted throughout the morning and afternoon.
Patient received her second dose. After her second dose she starting itching right away. When she woke up the next morning it was swollen and warm to the touch. As the day went on patient stated it spread and still warm to the touch. Patient was told to go to urgent care because it looked like it could be infected
2000 - neck pain, headache 2200 - mild body aches 0235 - severe chills, muscle/joint pain, headache. 0600 - fever 102.5F tympanic, took Tylenol 1000 mg + ice packs 0730 - temp 101.9 F; headache severe w/ nausea 0800 - took ibuprofen 600 mg; fatigue, took nap 0930 - temp 100.4 F 1400 - headache continues but much less severe; temp 99.0 F
received shingrix on 12/16/2021/did not receive 2nd dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 50 mcg of first dose on 16th December 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 27-Oct-2022 Reporter's comment: The patient stated that for patients 50 years or older, there was a time that was preferred in the 2 to 6 month time-frame to get the second dose of Shingrix. The administration approved dosing schedule for Shingrix was the first dose at month 0, followed by a second dose 2 to 6 months after the first dose. Disease control had provided guidance that if it had been more than 6 months since a patient received the first dose, they should get the second dose as soon as possible, patients did not need to restart the vaccine series. Additional supportive information: Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to incomplete course of vaccination. The details were reported for first dose of Shingrix.
Angreedams (L) thigh 6cm clarinex 5mg daily  cold compress
My lips started tingling; my face then became beet red; BP went way up; throat was scratchy; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 51 year old non pregnant female patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 21Apr2021 09:45 (Batch/Lot Number: EW0161) as DOSE 2, SINGLE for covid-19 immunisation. Also, received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right on 30 Mar2021 09:30 (Batch/Lot Number: ER2613 ) as DOSE 1, SINGLE for covid-19 immunisation as historical vaccine. Medical history included allergy to arthropod sting from an unknown date and unknown if ongoing. Concomitant medication(s) included colecalciferol (VITAMIN D [COLECALCIFEROL]) taken for an unspecified indication, start and stop date were not reported; vitamin c [ascorbic acid] (VITAMIN C [ASCORBIC ACID]) taken for an unspecified indication, start and stop date were not reported. The patient states that her lips started tingling on 21Apr2021 with outcome of recovering , her face then became beet red on 21Apr2021 with outcome of recovering , blood pressure went way up leading to blood pressure increased on 21Apr2021 with outcome of recovering, throat was scratchy on 21Apr2021 with outcome of recovering. The patient underwent lab tests and procedures which included blood pressure measurement which went way up. Therapeutic measures were taken as a result of this by taking her in ambulance to medical Center ER and observed after being given Benadryl, famotidine, and prednisone  No follow-up attempts are possible. No further information is expected.
pain at the sternum base; breathing problems; Diarrhea; Chills; Slight fever; Possible swollen lymph glands; Red arm; brain fog continued; Increased irritability; Vomiting; Extreme dizziness; Swollen, red arm; This is spontaneous report from a contactable consumer, the patient. A 69-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: Unknown), via unspecified route of administration in the left arm on 03Mar2021 at 21:00 as a single dose for COVID-19 Immunisation (at the age of 69 years age at vaccination). Prior to vaccination, the patient was not diagnosed with COVID-19. The patient's medical history included gastroesophageal reflux disease (GERD) and hypothyroidism. The patient was allergic to the Penicillin and most of the antibiotics and always had a problem with flu vaccine so since retired don't get it or other vaccines. The patient's concomitant medications included pantoprazole 20mg (MANUFACTURER: UNKNOWN) and levothyroxine112mg (MANUFACTURER UNKNOWN).The patient experienced swollen, red arm, vomiting, diarrhea, extreme dizziness, chills, slight fever, possible swollen lymph glands, increased irritability and brain fog on 04Mar2021 at 03:00am and she had to be in bed for almost 40 hours. The patient also experienced repeat of extreme vomiting, diarrhea and breathing problems secondary to pain at the sternum base on 14Mar2021. No Therapeutic measures taken for the adverse event. At the time of the report the clinical outcome of the events swollen, red arm, vomiting, diarrhea extreme dizziness, chills, slight fever, possible swollen lymph glands, increased irritability and brain fog were recovering and the events breathing problems and secondary to pain at the sternum base were unknown.   No follow-up attempts are possible. No further information is expected.
I am on the IUD and haven?t had a period in almost a year. After getting the shot I?ve had 3 separate instances of heavy spotting that lasted 2-3 days over the past month.  In addition, the shot seemed to affect my arthritis. The next day I woke up and pretty bad inflammation in almost every joint for almost a week. I?ve been recovering from long-covid since last December and had mostly recovered at time of 1st shot. I noticed since then a re-emergence of the fatigue and breathing issues. The re-emergence was not horrible or life threatening but very noticeable. I had a follow-up breathing test yesterday (05/20/2021) and there was a decline from the previous breathing test taken in March.
rash on back of neck & spread to face approx 2 hrs later; seen in clinic 930AM; mild pharyngitis & enlarged lymph node were noted; no fever develed; pt was referred to pvt MD;
patient presents with pain and erythema at injections site, general malaise with chills. No fever at time of evaluation. Pt sent to ER.
congestion in the 24hours after injection and swelling entire upper Right arm including right shoulder. With inflammation into right axilla very painful with mobility greatly decreased.